Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Z Badrichani

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Transplantation Proceedings|March 27, 2001
A20 and BCL proteins exert a broad and complementary cytoprotective effect in endothelial cells via blockade of NF-kappaB and NFATA Z Badrichani, C Ferran
Transplantation Proceedings|March 27, 2001
The BH4 domain of A1, an anti-apoptotic bcl family gene, is necessary and sufficient for its antiinflammatory function in endothelial cellsE Rocha, J Mahiou, A Z Badrichani, et al.
Blood|May 26, 1999
Overexpression of A1, an NF-kappaB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activationD M Stroka, A Z Badrichani, F H Bach, et al.
Transplantation Proceedings|February 1, 1997
Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation: a means of evaluating the role of endothelial cell activation in xenograft rejectionC Ferran, D M Stroka, A Z Badrichani, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1997
Xenotransplantation: progress toward clinical developmentC Ferran, A Z Badrichani, J T Cooper, et al.
The Journal of Clinical Investigation|February 18, 1999
Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaBA Z Badrichani, D M Stroka, G Bilbao, et al.
Transplantation Proceedings|March 20, 1999
A novel function for A20 in smooth muscle cells: inhibition of activation and proliferationM B Arvelo, A Z Badrichani, D M Stroka, et al.
Blood|April 18, 1998
A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosisC Ferran, D M Stroka, A Z Badrichani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Transplantation Proceedings|March 27, 2001
A20 and BCL proteins exert a broad and complementary cytoprotective effect in endothelial cells via blockade of NF-kappaB and NFATA Z Badrichani, C Ferran
Transplantation Proceedings|March 27, 2001
The BH4 domain of A1, an anti-apoptotic bcl family gene, is necessary and sufficient for its antiinflammatory function in endothelial cellsE Rocha, J Mahiou, A Z Badrichani, et al.
Blood|May 26, 1999
Overexpression of A1, an NF-kappaB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activationD M Stroka, A Z Badrichani, F H Bach, et al.
Transplantation Proceedings|February 1, 1997
Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation: a means of evaluating the role of endothelial cell activation in xenograft rejectionC Ferran, D M Stroka, A Z Badrichani, et al.
Advances in Nephrology From the Necker Hospital|January 1, 1997
Xenotransplantation: progress toward clinical developmentC Ferran, A Z Badrichani, J T Cooper, et al.
The Journal of Clinical Investigation|February 18, 1999
Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaBA Z Badrichani, D M Stroka, G Bilbao, et al.
Transplantation Proceedings|March 20, 1999
A novel function for A20 in smooth muscle cells: inhibition of activation and proliferationM B Arvelo, A Z Badrichani, D M Stroka, et al.
Blood|April 18, 1998
A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosisC Ferran, D M Stroka, A Z Badrichani, et al.
Pageof 1